p63 expression in odontogenic cysts.

[1]  B. Li,et al.  Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  C. Ligorio,et al.  High DeltaN p63 isoform expression favours recurrences in odontogenic keratocyst--odontogenic keratocystic tumour. , 2006, International journal of oral and maxillofacial surgery.

[3]  J. Bouchal,et al.  Immunohistochemical analysis of the biological potential of odontogenic keratocysts. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  S. Zhang,et al.  Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: a laser capture microdissection study of 15 cases , 2005, Histopathology.

[5]  Y. Abiko,et al.  Cell proliferation, apoptosis and apoptosis-related factors in odontogenic keratocysts and in dentigerous cysts. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[6]  A. Hirshberg,et al.  The correlation between epithelial cell proliferation and inflammation in odontogenic keratocyst. , 2004, Oral oncology.

[7]  H. Kumamoto,et al.  PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts. , 2004, International journal of oral and maxillofacial surgery.

[8]  G. Godoy,et al.  Immunohistochemical assessment of extracellular matrix components in syndrome and non-syndrome odontogenic keratocysts. , 2004, Oral diseases.

[9]  Narasimhan P. Agaram,et al.  Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. , 2004, Archives of pathology & laboratory medicine.

[10]  Y. K. Chen,et al.  Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas. , 2003, Clinical otolaryngology and allied sciences.

[11]  Y. K. Chen,et al.  Immunohistochemical demonstration of p63 in DMBA-induced hamster buccal pouch squamous cell carcinogenesis. , 2003, Oral diseases.

[12]  A. Piattelli,et al.  Calretinin expression in odontogenic cysts. , 2003, Journal of endodontics.

[13]  S. Douc-Rasy,et al.  TP53 family members and human cancers , 2003, Human mutation.

[14]  K. Kiuchi,et al.  p63 expression in normal human epidermis and epidermal appendages and their tumors , 2003, Journal of cutaneous pathology.

[15]  R. Mantovani,et al.  Complex Transcriptional Effects of p63 Isoforms: Identification of Novel Activation and Repression Domains† , 2002, Molecular and Cellular Biology.

[16]  R. Nenutil,et al.  Differential expression of p63 isoforms in normal tissues and neoplastic cells , 2002, The Journal of pathology.

[17]  J. Reis-Filho,et al.  p63 expression in normal skin and usual cutaneous carcinomas , 2002, Journal of cutaneous pathology.

[18]  S. Riethdorf,et al.  Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. , 2002, Human pathology.

[19]  W. Kim,et al.  Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. , 2002, Human pathology.

[20]  C. Weghorst,et al.  Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14ARF. , 2002, International journal of oncology.

[21]  M. Shear.  The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 3. Immunocytochemistry of cytokeratin and other epithelial cell markers. , 2002, Oral oncology.

[22]  M. Shear.  The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. , 2002, Oral oncology.

[23]  M. Oren,et al.  Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities* , 2002, The Journal of Biological Chemistry.

[24]  M. Shear,et al.  The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. , 2002, Oral oncology.

[25]  E. Sturgis,et al.  Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. , 2002, Human pathology.

[26]  A. Piattelli,et al.  Ki-67 expression in dentigerous cysts, unicystic ameloblastomas, and ameloblastomas arising from dental cysts. , 2002, Journal of endodontics.

[27]  A. Yang,et al.  On the shoulders of giants: p63, p73 and the rise of p53. , 2002, Trends in genetics : TIG.

[28]  U. Moll,et al.  p53, p63 and p73--solos, alliances and feuds among family members. , 2001, Biochimica et biophysica acta.

[29]  A. Piattelli,et al.  P53 protein expression in odontogenic cysts. , 2001, Journal of endodontics.

[30]  H. Kumamoto,et al.  Detection of cell cycle-related factors in ameloblastomas. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[31]  G. Blandino,et al.  From p63 to p53 across p73 , 2001, FEBS letters.

[32]  L. Barnes.  Surgical Pathology of the Head and Neck , 2000 .

[33]  J. Jen,et al.  AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Carey,et al.  Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells. , 2000, Carcinogenesis.

[35]  F. McKeon,et al.  Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. , 1999, The Journal of investigative dermatology.

[36]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[37]  R. Ralhan,et al.  pRb and p16 protein alterations in human oral tumorigenesis. , 1998, Oral oncology.

[38]  A. Piattelli,et al.  Differentiation of odontogenic keratocysts from other odontogenic cysts by the expression of bcl-2 immunoreactivity. , 1998, Oral oncology.

[39]  A. Piattelli,et al.  Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. , 1998, Oral oncology.

[40]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[41]  T. Li,et al.  Immunocytochemical expression of growth factors by odontogenic jaw cysts. , 1997, Molecular pathology : MP.

[42]  J. Bartek,et al.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.

[43]  T. Li,et al.  p53 expression in odontogenic keratocyst epithelium. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[44]  P. Slootweg.  p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[45]  T. Li,et al.  Epithelial cell proliferation in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[46]  R. DePinho,et al.  Inhibition of ras-induced proliferation and cellular transformation by p16INK4 , 1995, Science.

[47]  T. Li,et al.  Quantification of PCNA+ cells within odontogenic jaw cyst epithelium. , 1994, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[48]  P. Robinson,et al.  Discrimination of parakeratinised odontogenic keratocysts from other odontogenic and non-odontogenic cyst types by expression of a 38kd cell-surface glycoprotein. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[49]  D. Lane,et al.  p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. , 1992, Journal of clinical pathology.

[50]  H. Philipsen.  Keratocystic odontogenic tumour , 2005 .

[51]  N. Hayward,et al.  Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients , 2004 .

[52]  A. Iamaroon,et al.  A comparative study of epithelial cell proliferation between the odontogenic keratocyst, orthokeratinized odontogenic cyst, dentigerous cyst, and ameloblastoma. , 2004, Oral diseases.

[53]  R. Strocchi,et al.  Expression of transforming growth factor-beta 1 (TGF-beta 1) in odontogenic cysts. , 2004, International endodontic journal.

[54]  Y. Kwong,et al.  Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas , 2001 .